Tesamorelin

Why the N-terminal acyl group matters

Native GHRH is cleaved between residues 2 and 3 by dipeptidyl peptidase-4, which limits its useful window in biochemical assays. Tesamorelin carries a trans-3-hexenoyl group on Tyr1, and much of the published characterisation examines how this hydrophobic cap alters susceptibility to peptidase attack while leaving the receptor-binding face of the molecule intact. Structure–activity work in this family compares acylation against other stabilising strategies such as D-amino-acid substitution.

Receptor engagement

Like other GHRH-family peptides, tesamorelin is studied as an agonist at the pituitary GHRH receptor, a class B GPCR coupled to adenylate cyclase. Cell-based assays measure cyclic AMP accumulation and downstream growth hormone release from somatotroph cultures, with the full 1–44 sequence allowing comparison against truncated 1–29 fragments.

Metabolic and adipose research

• Investigation of the growth hormone–IGF-1 relationship as an intermediate step in observed metabolic changes
• Comparative studies against ghrelin-receptor secretagogues to separate GHRH-driven from GHS-R-driven effects

Analytical use

Store sealed vials at −20 °C, protected from light and moisture, and let a vial equilibrate to room temperature before breaking the seal. Reconstitute with bacteriostatic or sterile water added slowly against the glass wall, then rotate the vial gently until the cake dissolves; do not shake, as the acylated chain is surface-active and prone to foaming. Keep working solutions at 2–8 °C and label them with the lot number and date. Aliquot before freezing if the study spans multiple sessions, since repeated freeze–thaw cycles degrade larger peptides faster. Wear gloves and follow your laboratory's chemical hygiene and disposal procedures.